"We need to make sure current, well-established stem cell therapies, such as ordinary bone marrow transplants, do not require physicians to undertake a review and approval process by an institutional review board," Dr. Malone wrote in a formal TMA comment letter to TMB. "Bone marrow, peripheral blood stem cells, and cord blood are all used in transplants for hematopoietic reconstitution (usually referred to generically as bone marrow transplants)."

Action, Nov. 1, 2011